Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
19.58
+10.90 (125.58%)
At close: Oct 19, 2026, 4:00 PM EDT
19.57
-0.01 (-0.05%)
After-hours: Oct 19, 2026, 6:45 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $1.18 billion as of October 19, 2026. Its market cap has increased by 283.98% in one year.
Market Cap
1.18B
Enterprise Value
1.11B
1-Year Change
283.98%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from $538.37M to $1.18B, an increase of 118.98%. That is a compound annual growth rate of 13.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 19, 2026 | 1.18B | 310.51% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taysha Gene Therapies | 1.28B |
| GH Research | 1.25B |
| Nektar Therapeutics | 1.24B |
| Kardigan | 1.22B |
| Omeros | 1.20B |
| Damora Therapeutics | 1.19B |
| Savara | 1.18B |
| Syndax Pharmaceuticals | 1.16B |